Adcentrx Therapeutics
PrivateLast Round
Series A
Extension
Dec 5, 2023
Total Funding Raised
$114M
Company Overview
Adcentrx Therapeutics is a biotechnology company that develops protein conjugate therapeutics for the treatment of cancer and other life-threatening diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adcentrx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Adcentrx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 5, 2023 | ||||
| Series A Extension | Apr 24, 2023 | ||||
| Series A | Apr 28, 2021 |
Adcentrx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abio-X | Series A Extension |
| Boyu Capital | Series A |
| Zoo Capital | Series A |
| F-Prime Capital | Series A Extension |
| Eight Roads Ventures | Series A Extension |
| CBC Group | Series A |
| Trinity Innovation Fund | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2025
Will present at the 2025 ASCO Annual Meeting in Chicago.
- Apr 23, 2025
First clinical data for ADRX-0706 to be presented at 2025 ASCO Annual Meeting.
Adcentrx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adcentrx Therapeutics's valuation, stock price, and market status.